SEC Form 4 · accession 0001628280-26-043241
Organon & Co. · OGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rochelle B Lazarus
Director
Period of report
Jun 12, 2026
Accepted (ET)
Jun 15, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001821825
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF3,F1,F2 | — | Jun 12, 2026 | A | 17,857 | A | — | — | Common Stock | 17,857 | 81,141 | D |
Explanation of responses
- F1Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
- F2Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
- F3Holdings include phantom stock acquired in dividend reinvestment transactions on September 11, 2025, December 11, 2025, March 12, 2026 and June 11, 2026.